Singapore healthcare market: size, growth and outlook 2026–2032

The regional benchmark for quality and a hub for suppliers serving the Gulf and South Asia. Published estimates normalised to 2025 range from USD 7.7 bn to USD 30.8 bn; the Consulting Wallah central estimate is USD 24.0 bn, growing at about 9% a year to USD 43.9 bn by 2032. Scope differences between publishers explain most of the spread — the comparison table below states each one.

Growth is driven by ageing population: elderly ~16% of population today; over a quarter aged 65+ by 2030 (Insights10; ITA); government capacity build-out: 13,600 beds planned 2025-2030, 13 acute and 12 community hospitals by early 2030s (MOH); rising national health expenditure: projected USD 43-44 bn and 9% of GDP by 2030 (ITA).

Context that matters for buyers and suppliers: Public sector holds ~80% of hospital beds; private sector ~20%. Singapore planned to double hospital beds to more than 31,000 over the next decade. 17 acute hospitals (9 public, 8 private) with 11,736 beds as of Oct 2022; Parkway group 1,078 beds, Raffles 380, Mount Alvernia 319, Thomson 187. Five Transitional Care Facilities with ~700 beds received ~5,300 patients in 2024.

The chart shows the Consulting Wallah central estimate: published figures normalised to 2025, median taken, and projected at the median published growth rate. The published range for 2025 is USD 7.7 bn–USD 30.8 bn; differences are mostly scope.

Included: public and private hospital, clinic, diagnostic and long-term care services and the associated health expenditure. Excluded: pharmaceutical and device product sales, insurance premiums and health IT (covered in separate reports). Published totals differ mainly by whether products and insurance are folded in.

Shares as reported by the named sources; ranking is more reliable than the exact percentage.

• Public sector holds ~80% of hospital beds; private sector ~20% (US ITA Country Commercial Guide 2025)
• Singapore planned to double hospital beds to more than 31,000 over the next decade (US ITA Country Commercial Guide 2025)
• 17 acute hospitals (9 public, 8 private) with 11,736 beds as of Oct 2022; Parkway group 1,078 beds, Raffles 380, Mount Alvernia 319, Thomson 187 (J Hosp Manag Health Policy 2023)
• Five Transitional Care Facilities with ~700 beds received ~5,300 patients in 2024 (MOH)
• MIC@Home has served >2,500 patients and >12,700 bed-days since April 2024 (MOH)
• Singapore General Hospital ranked 9th of 250 hospitals in 2023 Global Hospital Rating; 13 JCI-accredited facilities (US ITA)
• More than 70% of medical device imports are re-exported; imports meet >80% of local demand (US ITA)
• Healthcare spending overtook defence spending in 2022, up SGD 0.9 bn (4.9%) to ~3.4% of GDP (government budget) (J Hosp Manag Health Policy 2023)
• Public healthcare regrouped into three clusters (SingHealth, NUHS, NHG) in 2017 (HealthXchange / SingHealth)
• Public hospitals to add 4,000 beds over six years; new Tengah hospital by early 2030s (Malay Mail (Health Minister, Mar 2024))

Where the GCC and India sit

• Singapore - public acute + community hospital beds: 12,000+ existing; ~2,800 to be added 2025-2030 (2025) — MOH Committee of Supply 2025
• Singapore - beds added since 2020 (all settings): 6,300+ (1,200 acute, 600 community hospital, 4,300 nursing home, 200 MIC@Home) (2025) — MOH
• Singapore - total beds planned (all settings) 2025-2030: 13,600 incl. 10,600 nursing home beds (2025) — MOH
• Singapore - medical device imports: USD 7,244 m (2024); USD 6,680 m (2025 est.); exports USD 13,186 m (2024) (2024) — US ITA citing IHS Markit
• Singapore - foreign patients drawn per year: almost 500,000 (2025) — US ITA Country Commercial Guide
• Singapore - polyclinics: 26 (end-2024) rising to 32 by 2030 (2024) — MOH

Consulting Wallah works this market from both sides: hospital groups in the UAE, Saudi Arabia, India and Bangladesh as buyers, and manufacturers in India, China, Singapore, Malaysia and the US as suppliers through the Network. Our observation is that registration status, in-country stock and structured quotations decide access in the GCC, while price and distributor reach decide it in India. CW observation

Opportunities we see: hospital redevelopment pipeline: Alexandra Hospital (1,300 beds from 2028), Eastern General Hospital (1,400 beds from 2029), Tengah General Hospital (early 2030s), NUH Kent Ridge to 1,500 beds by 2038 (MOH); medical device imports cover >80% of local demand; US share 24% (ITA); digital health, telemedicine, EHR and robotics (Nexdigm; MIC@Home mainstreamed April 2024).

Key companies named across the sources; local distributors and implementation partners matter as much as the brand in the GCC and India.

• Operators and investors: capacity, payer rules and licensing timelines decide returns; design central procurement and insurer contracting into the operating model before opening.
• Suppliers: registration, a local partner and payer-formulary presence are the gates; central tenders reward structured quotations and reliable supply over the lowest price.
• Hospital leaders: payer pressure makes the 25–35% of cost in supplies the margin lever — see the free executive assessment.

1. US International Trade Administration, Singapore Country Commercial Guide - Healthcare — trade.gov
2. Ministry of Health Singapore, Expanding Healthcare Capacity and Transforming the Healthcare Workforce (COS 2025) — moh.gov.sg
3. Insights10, Singapore Hospital Market Analysis — insights10.com
4. Nexdigm, Singapore Healthcare Infrastructure Market — nexdigm.com
5. MarketLine via DRI, Healthcare Providers in Singapore (Feb 2025) — dri.co.jp
6. Journal of Hospital Management and Health Policy, Development of the private hospitals in Singapore from 1983 to 2022 — jhmhp.amegroups.org
7. IG Singapore, 10 healthcare stocks to watch — ig.com
8. Ministry of Health Singapore, Assessing trend of Singaporeans seeking medical treatment in Malaysia — moh.gov.sg
9. NHG Health, New TTSH Medical Tower to house about 600 acute beds — nhghealth.com.sg
10. Ken Research, Singapore Healthcare Market 2026-2031 (robots-blocked; not fetched) — kenresearch.com
11. Insights10 (2024) — USD 6.60 bn (2023) to USD 11.46 bn (2030), CAGR 8.2%; scope: Country, sub-segment: Singapore hospital market (inpatient + outpatient hospital services) — source
12. Nexdigm (2025) — USD 21.4 bn (2024) to — (2030), CAGR 14.96% (2024-2030); scope: Country: Singapore healthcare infrastructure market (hospitals, clinics, nursing homes, rehab, health-tech); forecast value not shown publicly — source
13. MarketLine / GlobalData (2025-02) — USD 27.8 bn (page prints '$27.8 million'; unit appears to be a typo) (2024) to — (2029), CAGR 10.9% (2019-2024 historical); market grew 4.4% in 2024; scope: Country: Singapore healthcare providers market (inpatient, outpatient, long-term care, medical goods, collective services); outpatient care = 43.4% ($12.1 'million') in 2024 — source
14. Consulting Wallah Network — anonymised observations from procurement and business-setup work with hospital groups and suppliers in the UAE, India and Bangladesh (2024–26), used for the GCC/India outlook and the “what it means” section.
15. Method. Each published figure is normalised to a 2025 base using its own CAGR; the Consulting Wallah central estimate is the median of the normalised figures (or the stated scope where noted) projected at the median CAGR to 2032. Country figures are quoted as published; where we add a CW estimate it is labelled.